WG
FLGT icon

Winton Group’s Fulgent Genetics FLGT Stock Holding History

Winton Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,492
Closed -$279K – 883
2025
Q1 		$279K Buy
+16,492
New +$281K 0.02% 587
2023
Q3 		– Sell
-6,624
Closed -$245K – 822
2023
Q2 		$245K Sell
6,624
-14,696
-69% -$512K 0.02% 600
2023
Q1 		$666K Buy
21,320
+8,265
+63% +$266K 0.04% 588
2022
Q4 		$389K Sell
13,055
-4,683
-26% -$168K 0.03% 713
2022
Q3 		$676K Sell
17,738
-37,087
-68% -$1.86M 0.04% 550
2022
Q2 		$2.99M Sell
54,825
-7,662
-12% -$421K 0.16% 166
2022
Q1 		$3.9M Buy
62,487
+52,195
+507% +$3.44M 0.2% 94
2021
Q4 		$1.03M Sell
10,292
-32
-0.3% -$2.81K 0.06% 447
2021
Q3 		$929K Buy
10,324
+6,843
+197% +$622K 0.05% 541
2021
Q2 		$321K Buy
+3,481
New +$278K 0.02% 1150

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Winton Group's FLGT Position: Q2 2025 in Review

Winton Group sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 16,492 shares — an estimated $279K sold.

Winton Group first reported a position in FLGT in Q2 2021 and held it in 10 quarters. The position peaked at $3.9M in Q1 2022. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Winton Group reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Winton Group sold 16,492 Fulgent Genetics shares in Q2 2025, an estimated $279K.
  • Winton Group first reported a position in Fulgent Genetics in Q2 2021 and held it in 10 quarters.
  • Winton Group's Fulgent Genetics position peaked at $3.9M in Q1 2022.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Winton Group's 13F filing for Q2 2025, filed 14 Aug 2025.